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We isolated mucin-like glycoproteins from the conditioned medium of primary hamster tracheal epithelial (HTE) cell
culture and characterized them biochemically and immunologically. These glycoproteins were purified on Sepharose CL-
4B after Streptomyces hyaluronidase treatment and then by CsCl-density-gradient centrifugation in the presence of 4 M-
guanidinium chloride. The purified glycoproteins were resistant to digestion by chondroitin AC lyase, heparinase,
heparitinase and endo-N-acetylglucosaminidases A, D and H, but susceptible to endo-fl-galactosidase and keratanase.
SDS/PAGE demonstrated no contamination by low-molecular-mass proteins. The purified glycoproteins showed a peak
buoyant density of 1.56 g/ml in CsCl-density-gradient centrifugation, and contained 10% peptide and 90% carbohydrate
by weight. Carbohydrates in these glycoproteins contained N-acetylglucosamine, N-acetylgalactosamine, galactose,
fucose, sialic acid and a trace amount of mannose, but no uronic acid. Serine and threonine together accounted for 27%
of the total amino acid residues. In addition, the mucin-like glycoproteins exhibited blood-group A and B activities, and
very strong inhibitory activity for influenza A virus haemagglutination. With the use of the purified glycoprotein as an
antigen, six monoclonal antibodies that stained mucus granules in hamster tracheal epithelium were obtained. We
characterized the antibody produced by one of the clones, HM D46. We conclude that HTE cells cultured in the serum-
free medium secrete a glycoprotein with physicochemical properties similar to those known in various airways mucins.
INTRODUCTION
Mucin is a high-molecular-mass glycoprotein containing
oligosaccharide chains linked to serine/threonine via N-acetyl-
galactosamine [1-3]. Tracheobronchial mucin, rich in carbo-
hydrates (70-90 %) and low in peptide (10-20 %), exhibits a peak
buoyant density of 1.45-1.60 g/ml in CsCl-density-gradient
centrifugation [4-6]. The typical sugars present in these mucins
are D-N-acetylgalactosamine, D-N-acetylglucosamine, D-galac-
tose, L-fucose and sialic acid. Mucin peptide typically contains
30-50 serine+threonine residues/100 amino acid residues, high
amounts of glycine, alanine, glutamic acid and proline and low
amounts of cysteine and aromatic amino acids [2,7-9].
Most of the information about tracheobronchial mucins comes
from studies of mucins isolated from sputa of patients with cystic
fibrosis or chronic bronchitis [2,7,8], secretions in tracheal pouch
[10-14] or conditioned media of tracheal explant cultures [6,15-
18]. There are limitations and potential problems associated with
these types of studies. Mucins are secreted by goblet cells in the
surface epithelium and by mucus-secreting cells in submucosal
glands, and therefore the physicochemical data for tracheo-
bronchial mucins reported in the literature represent composite
properties of mucins from these two sources. In addition, mucins
isolated from the sputa of patients with airways infection or
inflammation are subjected to various modifications such as
proteinase degradation [19-21] and possibly glycosidase digestion
[22]. To study the products secreted from each of these two
secretory elements, cultures of isolated surface epithelial cells
[23,24] and submucosal gland cells [25] have been developed.
However, it has never been fully demonstrated that these cultured
cells secrete mucins.
We have previously developed a serum-free hormone-supple-
mented culture system for growing the surface epithelial cells of
hamster trachea (HTE cells) [26]. The defined medium developed
was based on the growth requirements of the cells [27]. These
requirements include insulin, transferrin, epidermal growth fac-
tor, cortisol, cholera toxin and a crude extract of bovine
hypothalamus. Cultured HTE cells were able to form new cilia
and mucus granules in confluent culture [26]. We [26] have
demonstrated the presence of mucin-type O-glycosidic linkages
in a high-molecular-mass glycoprotein secreted by HTE cells
cultured in this serum-free medium. Using a serum-supplemented
medium that we had established earlier [28], Kim et al. [29] also
reported a similar observation. In the present investigation we
have performed the detailed chemical analyses of the composition
of this glycoprotein and shown that this glycoprotein has
physicochemical properties similar to those of tracheobronchial
mucins. In addition, we have generated several monoclonal
antibodies with the use of this glycoprotein as an immunogen,
and shown them to stain secretory granules in the secretory cells
of hamster tracheal epithelium. One of these monoclonal anti-
bodies recognizes a poly-N-acetyl-lactosamine structure.
MATERIALS AND METHODS
Cell isolation and culture conditions
Syrian hamsters aged from 2 to 5 months, obtained from
Charles River Co. (Wilmington, MA, U.S.A.), were used in this
study. Differences in age and sex had no apparent effects on
yields of cell isolation and the performance of the cells in culture.
Cells were isolated from trachea by the proteinase method as
described in previous publications [23,26,28].
Abbreviation used: HTE cells, hamster tracheal epithelial cells.
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Primary cultures were normally initiated by plating 5 x 104
cells/60 mm-diam. culture dish coated with 1 ml of collagen gel
as previously described. The final concentration of collagen in
the substratum was 0.24 %. The serum-free culture system
developed in our laboratory was suitable for HTE cell growth
and differentiation [23]. The medium consisted of Ham's F12
nutrients (GIBCO, Grand Island, NY, U.S.A.) supplemented
with insulin (5 ,ug/ml) (Sigma Chemical Co., St. Louis, MO,
U.S.A.), transferrin (5 ,ug/ml) (Sigma Chemical Co.), epidermal
growth factor (10 ng/ml) (Upstate Biotechnology, Lake Placid,
NY, U.S.A.), cortisol (1 #M, or 0.1 zM-dexamethasone) (Sigma
Chemical Co.), cholera toxin (20 ng/ml) (List Biological, Camp-
bell, CA, U.S.A.) and bovine hypothalamus extract (15 ,ug/ml).
Vitamin A (retinol) (Sigma Chemical Co.) was added at 1 ,UM.
Bovine hypothalamus was obtained from Pel-Freeze Biologicals
(Rogers, AR, U.S.A.) and the extract was prepared in the
laboratory according to the method of Maciag et al. [30].
Hormonal stocks were prepared at dilutions of 1/500 or 1/1000
as described in the literature [31-33]. Retinol was handled under
yellow lighting to minimize photodegradation, and it was dis-
solved in dimethyl sulphoxide and stored in liquid N2 until
needed. Medium was changed 2 days after plating and every
other day thereafter. Conditioned media were collected from
day 7 to day 14 and stored at -20 °C after centrifugation to
remove cell debris. The radiolabelled precursor [3H]glucosamine
(20 ,Ci/ml; specific radioactivity 25-40 Ci/mmol) (ICN, Irvine,
CA, U.S.A.) was added to the medium of a few dishes for
monitoring glycoprotein synthesis and secretion in culture.
Biochemical analyses of glycoproteins secreted in culture
About 5 litres of conditioned media were collected from both
vitamin A-treated and untreated cultures. The conditioned media
were extensively dialysed against water at 40 °C and freeze-dried.
The freeze-dried materials were reconstituted in 50 ml of a SDS
sample buffer containing 3 % (w/v) SDS and 5% (v/v) 2-
mercaptoethanol [34-36] and treated at 100 °C for 3-5 min. The
solution was spun at 10000 g for 20 min to remove the precipitate
before being subjected to Sepharose CL-4B (Pharmacia Fine
Chemicals, Piscataway, NJ, U.S.A.) chromatography as de-
scribed previously [26]. The void-volume (VJ) materials were
further dialysed against water at room temperature. After being
freeze-dried, the sample was then treated with Streptomyces
hyaluronidase (10 units/ml) (Calbiochem, San Diego, CA,
U.S.A.) at pH 6.0 at 37 °C for 24 h in the presence of the
proteinase inhibitor phenylmethanesulphonyl fluoride (2 mM)
(Sigma Chemical Co.). The sample was rechromatographed on
Sepharose CL-4B. The V1 materials from the second Sepharose
CL-4B column chromatography were subjected to CsCl-density-
gradient centrifugation at a starting density of 1.50 g/ml in the
presence of 4 M-guanidinium chloride (Pierce Chemical Co.,
Rockford, IL, U.S.A.) [4-6]. The fractions at densities between
1.50 and 1.62 g/ml were combined, dialysed against water and
used for compositional analyses and as an immunogen for
monoclonal antibody production.
The purified glycoproteins were further treated with various
glycosidases (Seikagaku Kogyo Co., Tokyo, Japan) according to
the procedures suggested by manufacturer. Both endoglycosidase
A and endoglycosidase H treatments were carried out at pH 6.0
at 0.02 unit/ml, and endoglycosidase D treatment was at pH 6.5
at 0.02 unit/ml. Heparinase and heparitinase were both used at
5 units/ml at pH 7.0. Chondroitin AC lyase was used at 1 unit/
ml at pH 6.0. Neuraminidase and a-fucosidase (Boehringer
Mannheim Biochemical, Indianapolis, IN, U.S.A.) were used at
pH 7.0, at 0.2 unit/ml and 100 ,ug/ml respectively. Two types of
endo-fl-galactosidase, from Escherichia freundii (Seikagaku
Kogyo Co.) and Bacteroides fragilis (Boehringer Mannheim
Biochemical), were used at 0.02 unit/ml at pH 6.0. Keratanase
from Pseudomonas sp. IFO-13309 (Seikagaku Kogyo Co.) was
used at 1 unit/ml at pH 7.0. All of these treatments were carried
out in the presence of 2 mM-phenylmethanesulphonyl fluoride
and at 37 °C for 20 h. Periodic acid treatment was carried out at
pH 4.5 in the presence of 0.01 M-periodate for 20 h at 4 'C.
Amino acid compositions of isolated mucin-like glycoproteins
were determined in a Beckman 6300 high-performance amino
acid analyser (Beckman Instruments, Palo Alto, CA, U.S.A.)
after acid hydrolysis (6 M-HCI at 100 'C for 24 h under vacuum).
Duplicate samples were analysed. Hexosamines were determined
by an h.p.l.c. method [37] after acid hydrolysis (4 M-HCI at
100 'C for 5 h), neutral sugars were determined by a g.l.c.
method after methanolysis and trimethylsilylation [7] and sialic
acid was determined by a modified thiobarbituric acid method
[38]. For monitoring the carbohydrate (neutral sugar) in the
column fractions, the phenol/H2SO4 method [39] was employed.
Immunology methods
Mice were immunized with purified mucin-like glycoproteins
at 10 ,ug of protein per mouse per injection. After four injections
over a period of 2 months, mice spleen cells were fused with
myeloma SP2/0 [40]. The hybrids were selected in the HAT
(hypoxanthine/aminopterin/thymidine) medium. A radioimmu-
noassay was developed to screen these hybrids. Micro-titre plates
were coated with 5 ng of purified mucin-like glycoconjugate/well
(based on the protein determination). After being washed three
times with phosphate-buffered saline (0.15 M-NaCl/20 mm-
sodium phosphate buffer, pH 7.0) containing 0.05 % (v/v) Tween
20 and then treated with BSA (2 mg/ml) in phosphate-buffered
saline containing 0.05 % Tween 20, each well was exposed to the
conditioned medium of hybridoma cells. The control well was
exposed to the original culture medium, RPMI medium con-
taining 10% (v/v) foetal bovine serum. 125I-labelled goat anti-
(mouse IgG) antibody (from NEN, Boston, MA, U.S.A.) was
used to identify the positive clone. The radioactivity bound to
each well was determined with a y-radiation scintillation counter.
Positive clones were further cloned by a serial-dilution method
until every well of diluted culture produced antibody that reacted
with purified mucin antigen. The immunohistochemical staining
of HTE cells was carried out in frozen sections of hamster
trachea with the Vectastain ABC kit (peroxidase-based) (Vector
Laboratories, Burlingame, CA, U.S.A.) to identify the cells that
react with the monoclonal antibodies. For classifying the type of
immunQglobulin secreted by hybridoma clones, a screening
subtype kit was used. This kit detects mouse forms IgG1, IgG2.,
IgG2b, IgG3 and IgM and K and A light chains.
Blood-group A, B and H (0) titres for the purified glycoprotein
were measured by haemagglutination inhibition with a 1%
suspension of human erythrocytes according to the procedure
described previously [41]. Anti-A and anti-B sera were obtained
from Hyland Co. (Costa Mesa, CA, U.S.A.) and anti-H lectin
(Ulex europeus) was from Sigma Chemical Co. Influenza-virus
haemagglutination inhibition activity was measured similarly
[41] with heat-inactivated influenza A virus and a 1 % suspension
of chicken erythrocytes. Immunoblot analysis was carried out as
described by Towbin et al. [42].
RESULTS
Isolation and characterization of mucin-like glycoproteins
Fig. l(a) shows the Sepharose CL-4B elution profiles of the
concentrated conditioned media from retinol-treated and un-
treated HTE cell cultures and of the original culture medium.
The two peaks detected by the 280 nm absorbance were only
observed in the conditioned media from retinol-treated and
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Fig. 2. CsCl/guanidinium chloride-density-gradient centrifugation of the
VO materials from the second Sepharose CL4B run of culture
medium obtained from the retinol-treated cultures
The [3H]glucosamine-labelled VJ materials were dissolved in 4 M-
guanidinium chloride and then adjusted with crystalline CsCl to an
initial density of 1.50 g/ml. Centrifugation was carried out at
100000 g (40000 r.p.m. in a Beckman type 65 rotor) for 72 h at
15 'C. Fractions were collected from the bottom of the centrifuge
tube. The radioactivity (0) and the density (@) of each fraction
were determined.
uI.-,, .
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Fig. 1. Sepharose CL-4B (5 cm x 120 cm) chromatography profile of con-
centrated conditioned media from retinol-treated (-) and untreated
(0) HTE cultures and the original culture medium (A)
Concentrated conditioned media were prepared from HTE cultures
as described in the text. These concentrated conditioned media
(50 ml) were adjusted to contain SDS and 2-mercaptoethanol at
final concentrations of 3% (w/v) and 50% (v/v) respectively. The
entire fluids were then loaded on to a Sepharose CL-4B column
(5 cm x 120 cm). The column was eluted with phosphate-buffered
saline containing 0.1 0% SDS and 0.5 % 2-mercaptoethanol. Protein
was monitored by absorbance at 280 nm. The recovery for the
column was 85 %, based on the protein determination. (a) Peak I
and II fractions were separately pooled and dialysed. The peak I
fractions, after being freeze-dried, were further treated with
hyaluronidase and chromatographed on the same column (b).
Protein (-) and carbohydrate (Ol) measurements were carried out
for each fraction by the absorbance at 280 nm and 490 nm (phenol/
H2SO4 method) respectively. Void-volume fractions (V1) were
combined.
untreated cell cultures but not for the culture medium not
exposed to HTE cells. About 5-fold more material (on the basis
of the absorbance at 280 mm) was secreted by the HTE cells
treated with retinol than by the untreated cells. The peak I and
peak II materials were separately pooled and dialysed against
water. Because peak II materials have a low carbohydrate content
(25 %) and low serine and threonine contents (12 %), suggesting
the absence or low content of mucin, they were not studied
further. The peak I material was treated with hyaluronidase and
subjected to Sepharose CL-4B chromatography (Fig. lb). Ap-
prox. 20% of the materials was resistant to hyaluronidase and
excluded from the column. The hyaluronidase-resistant V1 mater-
ials were further purified by equilibrium-CsCl-density-gradient
centrifugation in the presence of 4 M-guanidinium chloride (Fig.
2). With the use of [3H]glucosamine labelling to monitor the
separation, a major but broad radioactive peak at buoyant
density between 1.50 and 1.62 g/ml with a peak buoyant density
at 1.56 g/ml was obtained. Rechromatography of the materials
from different densities on the Sepharose CL-4B column showed
that all of them remained in the V1 peak (results not shown).
Therefore the materials with buoyant densities between 1.50 and
1.62 g/ml were pooled, dialysed against water and freeze-dried.
A total of 2.7 mg of the purified mucin-like glycoprotein was
obtained from 5 litres of culture medium from the retinol-treated
HTE cell culture.
The isolated glycoprotein did not enter the 7.5 % PAGE on
electrophoresis in the presence of SDS and 2-mercaptoethanol,
nor was low-molecular-mass protein band detected by silver
stain (results not shown). The purified material was treated with
various glycosidases specific for N-glycoproteins and proteo-
glycans. Chondroitin AC lyase, heparitinase, heparinase and
endoglycosidases A, D and H did not degrade the molecule, as
demonstrated by the complete recovery of the glycosidase-treated
material in the V1' of the Sepharose CL-4B column (results not
shown). Endo-/J-galactosidases from Escherichia and Bacteroides
and keratanase removed 65 %, 40% and 30% of the labelling of
the mucin-like glycoproteins respectively.
The purified material contains 10% protein and 90% carbo-
hydrate by weight (Table 1). The sugars present in the mucin-like
glycoproteins were galactose, N-acetylgalactosamine, N-acetyl-
glucosamine, fucose and sialic acid (Table 1). Only a trace
amount of mannose was detected, and uronic acid was undetect-
able. Serine and threonine were the major amino acids, which
accounted for 27% of the amino acid residues (Table 1). The
contents of other amino acids such as glutamic acid, glycine,
alanine, aspartic acid and proline were also high, and together
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Table 1. Amino acid and carbohydrate composition of mucin-like
glycoprotein secreted by primary HTE cell culture
Mucin-like glycoprotein was purified as described in the text and the
final volume of the purified material was 60 ml. The protein
concentration was determined from the amino acid composition.
The carbohydrate content was the sum of the individual sugar
composition. Abbreviation: N.D., not determined.
Amino acid or carbohydrate composition
(Residues/ 1000
amino acid residues) (,ug/ml) (%)
Protein 4.20 9.7
Aspartic acid 88 0.39
Threonine 135 0.54
Serine 137 0.48















Fucose 183 1.0 2.3
Galactose 2000 12.0 27.6
N-Acetylgalactosamine 600 4.4 10.1
N-Acetylglucosamine 2157 15.8 36.3
Sialic acid* 515 5.3 12.2
Mannose 133 0.8 1.8
Uronic acid 0 0 0
* Calculated as N-acetyl derivative.
50 urn
Fig. 3. Immunohistochemical staining of hamster tracheal epithelium with
monoclonal antibodies specific to mucin-like glycoprotein
Frozen sections of hamster trachea were fixed and reacted with
HM D46 (1:500 dilution). Vectastain ABC kit (peroxidase-based)
was used to identify the positive reacting stain. Other monoclonal
antibodies, HM D20, HM D5, HM D36, HM F18 and HM G23,
had similar results. Key: L, lumen; E, epithelium.
Table 3. Effects of glycosidases and periodate treatment on the
radioimmunoassay reactivity of mucin-like glycoprotein to the
monoclonal antibody HM D46
Treatments were carried out as indicated in the Materials and
methods section. V' fractions from Sepharose CL-4B chromato-
graphy were used in this study. A 50 4u1 sample from each fraction
was dried in the 96-well micro-titre plate and used for radio-
immunoassay as described in the text. The value of each radio-
immunoassay count was then divided by the total radioactivity
(c.p.m.) in the 50,ul volume and the result expressed as c.p.m./unit.
An average from these five fractions in the VJ peak was used. The
background count represents the radioactivity without the primary
antibody in the radioimmunoassay.
Table 2. Blood group and influenza A virus haemagglutination inhibition
activities of purified mucin-like glycoprotein Treatment
Radioimmunoassay
(c.p.m./unit)
The blood group activity was measured by the minimum con-
centration of mucin-like glycoprotein that inhibited haemagglutin-
ation between anti-A serum (1: 64 dilution) and 1% blood-group A
erythrocytes, anti-B serum (1:64 dilution) and blood-group B
erythrocytes, and Ulex europeus lectin and blood-group 0
erythrocytes as described in ref. [41]. The influenza A virus
haemagglutination inhibition was measured as the minimum con-
centration of the glycoprotein that inhibits chicken erythrocyte

























residues. The aromatic amino acids phenylalanine and tyrosine
were present in trace amounts. The purified glycoprotein had
blood-group A and B activities but no blood-group H activity,
and inhibited influenza A virus haemagglutination (Table 2).
Production of monoclonal antibodies that stain mucus granules
The purified mucin-like glycoproteins were used to immunize
mice to produce monoclonal antibodies. More than 200 hybrid-
oma clones were screened by the radioimmunoassay method.
About 16 active and stable hybridoma clones were obtained. On
the basis of the radioimmunoassay results, the six clones with
activities 5-fold above the background control were characterized
further. Two of the monoclonal antibodies, HM D36 and














Hamster tracheal mucin in culture
HM F18 and HM G23) secreted IgM. All of them reacted with
mucus granules and the apical surface of epithelium in hamster
tracheal epithelium (Fig. 3). Furthermore, the stain was observed
only in the epithelial layer and there was no stain in the cartilage
and interstitial layer. Treatment of tissue sections with secondary
antibody alone did not show any staining (results not shown).
Radioimmunoassay analysis of the gel-filtration fractions indi-
cated that these antibodies recognized mainly the Vk materials
(results not shown). These results were confirmed by the Western-
blot analysis, which showed that the antibody reacted only with
materials that remained at the origin of the 7.5 % gel. To
characterize the epitope of one of these antibodies, the mucin-
like glycoproteins were treated with endo-,f-galactosidase, per-
iodic acid and other glycosidases, and then treated with this
antibody. As shown in Table 3, the epitope of HM D46 was
completely destroyed by the E.freundii endo-/J-galactosidase and
periodic acid treatments. Endo-fi-galactosidase from Bacteroides
and Pseudomonas keratanase destroyed 82 % and 73 % of the
epitope respectively. Other glycosidases did not affect the epitope.
DISCUSSION
We have previously demonstrated that HTE cells grown in this
serum-free medium produced new cilia as well as new mucus
granules [26]. Evidence of mucin-like glycoprotein secretion in
culture was based on the incorporation of [3H]glucosamine into
glycoproteins excluded by Sepharose CL-4B and the presence
of 3H-labelled galactosaminitol in purified glycoprotein after
fl-elimination and acid hydrolysis [26]. In the present work,
we purified enough mucin-like glycoproteins from the culture
medium to carry out detailed physicochemical characterization
and to address the question of whether or not the differentiated
HTE cells in culture secrete mucins. Detailed chemical analyses
showed that 10% of the purified mucin-like glycoproteins is
protein that has high serine+threonine (27%), glutamic acid,
aspartic acid, glycine and proline contents and is low in aromatic
acids. The amino acid composition of this glycoprotein is similar
to that of mucin but with a minor variance. For example, the
serine + threonine content is somewhat lower than that (30-50%)
found in other airways mucins. In addition, glutamic acid and
aspartic acid contents are somewhat higher than those in other
airways mucins [2,6,7,9]. The five sugars N-acetylgalactosamine,
N-acetylglucosamine, galactose, fucose and sialic acid, typically
found in tracheobronchial mucins, are present in this purified
glycoprotein. The presence of a trace amount of mannose in the
purified glycoprotein suggests either a contamination of a small
amount of glycoprotein that contains asparagine-linked oligo-
saccharide, or the oligosaccharides being a part of the mucin-like
glycoprotein. In the former possibility, the contamination of N-
linked glycoprotein in the purified material must be very small,
because we observed no change in the elution profile of the
purified mucin-like glycoprotein after the treatment with endo-
glycosidases A, D and H. The latter possibility may exist because
the sequencing data of the cDNA of the intestinal apo-mucin
suggest several possible glycosylation sites for asparagine-linked
carbohydrates [43]. However, it has never been conclusively
demonstrated that mucin contains N-linked oligosaccharides.
We could not unequivocally distinguish these two possibilities at
the present time. Further study is needed to answer this important
question.
There is strong evidence, however, that the mucin-like
glycoprotein is free of xylose-linked carbohydrates, which is
characteristic of glycosaminoglycans excluding keratan sulphate.
For instance, we could not detect any uronic acid in the mucin-
like glycoprotein by g.l.c. (Table 1). In addition, we have
demonstrated a complete resistance of the purified glycoprotein
to the enzymes that degrade hyaluronic acid and xylose-linked
carbohydrates present in glycosaminoglycans. These enzymes
include Streptomyces hyaluronidase, chondroitin AC lyase,
heparinase and heparitinase.
Hamster mucin has blood-group A and B activities, and no
blood-group H activity, suggesting that all of the blood-group H
determinants are capped with either a3-linked N-acetylgalactos-
amine or galactose because the blood-group H determinant is
the precursor for blood groups A and B [41]. On the basis of
this result we would predict that the activities of 3-N-acetyl-
galactosaminyltransferase and a3-galactosyltransferases would
be much higher than the al -.2-fucosyltransferase activity in the
cultured HTE cells. The presence of a strong inhibitory activity
of influenza A virus haemagglutination suggests the presence of
a2,6-linked sialic acid at the non-reducing termini of sugar
chains [44]. Furthermore, the purified glycoproteins exhibit a
peak CsCl buoyant density at 1.56 g/ml, which is well within the
range expected for tracheobronchial mucins. These results sug-
gest that the differentiated HTE cells in culture secrete a high-
molecular-mass glycoprotein that has physicochemical properties
similar to those of tracheobronchial mucins with some minor
variance in amino acid composition. This is the first time that
a detailed chemical composition of mucin-like glycoprotein
secreted by cultured tracheal epithelial cells has been reported. In
previous studies the tracheobronchial mucins have been isolated
in vivo from sputum [2,7-9], or pouch [11-14], or in vitro from
conditioned media of tracheal explant cultures [6,15-18]. These
mucins are secreted by both the goblet cells at the surface
epithelium and the submucosal mucin-secreting cells. It has not
been possible to discriminate between the properties of mucins
produced by each of these two mucin-secreting elements. The
cells in this primary culture system are derived from the surface
epithelium, and the data in this paper may represent the properties
ofmucins produced by the secretory cells in the surface epithelium
of hamster trachea.
Kim et al. [29] used the serum-containing culture conditions
previously developed in our laboratory [28] to demonstrate the
secretion of mucin-like glycoprotein by HTE cells. Our present
results show that serum is not required for HTE cell differenti-
ation. The serum-free hormone-supplemented medium provides
numerous advantages over the serum-supplemented condition.
For instance, serum contains many macromolecules that may
hinder the isolation and characterization of mucin-like molecules
produced in culture. Furthermore, serum also contains many
growth factors and hormones that will interfere with the
regulation of mucin synthesis in culture. In the present paper we
have shown that it is possible to demonstrate mucin synthesis
in a serum-free system. A similar conclusion has been recently
demonstrated in human tracheobronchial epithelial cells [45].
The other interesting finding in this study is that the six
monoclonal antibodies generated by the mucin-like glycoprotein
purified from the conditioned medium react not only with the
antigen but also with the mucus granules in airway epithelium.
We have obtained six monoclonal antibodies that react with
mucin-like glycoconjugates purified from the culture medium.
These antibodies recognize not only the mucin-like glycoprotein
in cell extract and conditioned medium but also the mucus-
secreting granules in vivo. These results suggest that mucin
isolated from the conditioned medium and the mucin in mucus-
secreting granules of hamster tracheal epithelium share similar
carbohydrate epitopes. We have observed a total destruction of
the epitope of one of the monoclonal antibodies (HM D46) by
periodate, which suggests that the epitope is carbohydrate in
nature. Extensive damage to the epitope by endo-,6-galactosidase
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In this study we also demonstrated that the secretory activity
in hamster cells is vitamin A-dependent. Vitamin A enhances the
secretion of mucin-like glycoprotein by HTE cells more than 5-
fold. This is consistent with a previous study that utilized
[3H]glucosamine labelling and histochemical staining methods
[26]. The importance of vitamin A in the homoeostasis of
mucociliary epithelium is well known. Under vitamin A-depleted
conditions squamous-cell metaplasia occurs in hamster airway
epithelium. Normally, mucus secretion in the airway lumen is
low. However, this phenomenon is reversed with a single
treatment with vitamin A or its derivatives (retinoids). At present,
the mechanism underlying the vitamin A-controlled airway cell
differentiation is not known. The differentiated HTE cell culture
system and the mucin-specific antibodies will facilitate further
study in understanding the role of vitamin A in the regulation of
mucin secretion.
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